Table 6.6h

Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005

Recipients with Pancreas Transplant Alone (PTA) Transplants

  Year of Transplant
2001 2002 2003 2004 2005
Discharge Regimen (w/ or w/o Steroid Use) CyA+MMF At Discharge (N) 6 4 2 1 -
At Discharge (%) 100.0% 100.0% 100.0% 100.0% -
6 Months PostTx (%) 16.7% 50.0% 100.0% 100.0% -
1 Year PostTx (%) 16.7% 50.0% 100.0% 100.0% -
2 Years PostTx (%) 0.0% 25.0% 50.0% 100.0% -
3 Years PostTx (%) 0.0% 0.0% 0.0% - -
CyA+Siro At Discharge (N) - 1 1 1 -
At Discharge (%) - 100.0% 100.0% 100.0% -
6 Months PostTx (%) - 100.0% 100.0% - -
1 Year PostTx (%) - 100.0% - - -
2 Years PostTx (%) - 100.0% - - -
3 Years PostTx (%) - 0.0% - - -
Siro+MMF At Discharge (N) 1 - 1 - 2
At Discharge (%) 100.0% - 100.0% - 100.0%
6 Months PostTx (%) 0.0% - 100.0% - 100.0%
1 Year PostTx (%) 0.0% - 100.0% - 100.0%
2 Years PostTx (%) 0.0% - 100.0% - 0.0%
3 Years PostTx (%) 0.0% - 0.0% - 0.0%
Tac+Aza At Discharge (N) 2 1 - 2 -
At Discharge (%) 100.0% 100.0% - 100.0% -
6 Months PostTx (%) 100.0% 100.0% - 100.0% -
1 Year PostTx (%) 100.0% 0.0% - 100.0% -
2 Years PostTx (%) 100.0% 0.0% - 50.0% -
3 Years PostTx (%) 100.0% 0.0% - - -
Tac+MMF At Discharge (N) 81 84 61 61 91
At Discharge (%) 100.0% 100.0% 100.0% 100.0% 100.0%
6 Months PostTx (%) 77.3% 82.1% 86.9% 78.3% 89.9%
1 Year PostTx (%) 68.3% 67.7% 75.2% 69.9% 84.6%
2 Years PostTx (%) 59.1% 60.4% 54.7% 59.6% 84.6%
3 Years PostTx (%) 51.1% 53.0% 48.1% 59.6% -
Tac+Siro At Discharge (N) 9 15 18 13 18
At Discharge (%) 100.0% 100.0% 100.0% 100.0% 100.0%
6 Months PostTx (%) 55.6% 86.7% 66.7% 84.6% 77.8%
1 Year PostTx (%) 44.4% 80.0% 61.1% 61.5% 72.2%
2 Years PostTx (%) 33.3% 65.5% 50.0% 25.6% 0.0%
3 Years PostTx (%) 33.3% 56.1% 40.0% - 0.0%


Source: OPTN/SRTR Data as of May 1, 2007.

Regimen change is defined as being on different drug combination at follow-up comparing to discharge, or indication of conflicting regimen (CyA vs. Tac; MMF/MPA vs. Aza; Siro vs. Evero) during follow-up period, or graft failure/death. Addition or deletion of steroids is not considered a regimen change.Rates are calculated for the most common discharge regimens.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.

See Technical Notes for further details.